Literature DB >> 33751206

Effectiveness of patient decision aids in women considering psychotropic medication use during pregnancy: a literature review.

Lucy C Broughton1, Natalie J Medlicott2, Alesha J Smith2.   

Abstract

Women face complicated decisions regarding psychotropic medication use during pregnancy. Patient decision aids (PDAs) could be a valuable tool to assist with decision-making. The objective of this review was to evaluate the effectiveness of PDAs in this population. A systematic search of the literature was conducted using PRISMA guidelines. Three major databases were searched to identify articles published between 2006 and June 2020. Studies were included if they evaluated use of a PDA for women considering medication for mental illness during pregnancy. A total of 4629 titles were returned from the search; however, only three studies met inclusion criteria and were selected for analysis. Two were pilot randomised controlled trials in women considering antidepressant use during pregnancy, and one was a non-randomised study in women considering medication for the treatment of opioid use disorder (OUD). The PDAs had good acceptability across all three studies. The randomised trials assessed knowledge, decisional conflict, depression, and anxiety, with non-significant trends towards reduced decisional conflict and anxiety in the PDA groups. PDAs have the potential to assist women with mental illnesses to make decisions regarding medication use during pregnancy; however, current evidence is too limited to evaluate the effectiveness of PDAs for this population.

Entities:  

Keywords:  Decision making; Mental illness; Patient decision aid; Pregnancy; Psychotropic

Mesh:

Substances:

Year:  2021        PMID: 33751206     DOI: 10.1007/s00737-021-01118-3

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  50 in total

Review 1.  Decision aid tools to support women's decision making in pregnancy and birth: a systematic review and meta-analysis.

Authors:  Marylène Dugas; Allison Shorten; Eric Dubé; Maggy Wassef; Emmanuel Bujold; Nils Chaillet
Journal:  Soc Sci Med       Date:  2012-03-14       Impact factor: 4.634

2.  Primary care physician's attitudes and practices regarding antidepressant use during pregnancy: a survey of two countries.

Authors:  Justin L C Bilszta; Shauna Tsuchiya; Kwiwon Han; Anne E Buist; Adrienne Einarson
Journal:  Arch Womens Ment Health       Date:  2010-11-30       Impact factor: 3.633

3.  Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices.

Authors:  Paula M Frew; Diane S Saint-Victor; Margaret Brewinski Isaacs; Sonnie Kim; Geeta K Swamy; Jeanne S Sheffield; Kathryn M Edwards; Tonya Villafana; Ouda Kamagate; Kevin Ault
Journal:  Clin Infect Dis       Date:  2014-12-15       Impact factor: 9.079

4.  Offspring Outcomes in Studies of Antidepressant-Treated Pregnancies Depend on the Choice of Control Group.

Authors:  Chittaranjan Andrade
Journal:  J Clin Psychiatry       Date:  2017-03       Impact factor: 4.384

5.  SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.

Authors:  Anick Bérard; Odile Sheehy; Jin-Ping Zhao; Évelyne Vinet; Sasha Bernatsky; Michal Abrahamowicz
Journal:  Br J Clin Pharmacol       Date:  2017-01-18       Impact factor: 4.335

6.  Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling.

Authors:  A Einarson; P Selby; G Koren
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

7.  Developing a quality criteria framework for patient decision aids: online international Delphi consensus process.

Authors:  Glyn Elwyn; Annette O'Connor; Dawn Stacey; Robert Volk; Adrian Edwards; Angela Coulter; Richard Thomson; Alexandra Barratt; Michael Barry; Steven Bernstein; Phyllis Butow; Aileen Clarke; Vikki Entwistle; Deb Feldman-Stewart; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Nora Moumjid; Al Mulley; Cornelia Ruland; Karen Sepucha; Alan Sykes; Tim Whelan
Journal:  BMJ       Date:  2006-08-14

8.  Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

Authors:  Lee S Cohen; Lori L Altshuler; Bernard L Harlow; Ruta Nonacs; D Jeffrey Newport; Adele C Viguera; Rita Suri; Vivien K Burt; Victoria Hendrick; Alison M Reminick; Ada Loughead; Allison F Vitonis; Zachary N Stowe
Journal:  JAMA       Date:  2006-02-01       Impact factor: 56.272

9.  Postpartum bonding: the role of perinatal depression, anxiety and maternal-fetal bonding during pregnancy.

Authors:  S Dubber; C Reck; M Müller; S Gawlik
Journal:  Arch Womens Ment Health       Date:  2014-08-05       Impact factor: 3.633

10.  Perinatal antidepressant use: understanding women's preferences and concerns.

Authors:  Cynthia L Battle; Amy L Salisbury; Casey A Schofield; Samia Ortiz-Hernandez
Journal:  J Psychiatr Pract       Date:  2013-11       Impact factor: 1.325

View more
  1 in total

1.  The role of prenatal exposure to antidepressants, anxiolytic, and hypnotics and its underlying illness on the risk of miscarriage using BIFAP database.

Authors:  Álvaro Kitchin; Consuelo Huerta; Ana Llorente-García; David Martínez; Paloma Ortega; Lucía Cea-Soriano
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-06-18       Impact factor: 2.732

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.